|1.||Kim, Jeong-Keun: 3 articles (08/2014 - 01/2010)|
|2.||Lim, Young-Hee: 3 articles (08/2014 - 01/2010)|
|3.||Lee, Eun-Ok: 2 articles (05/2014 - 01/2011)|
|4.||Kim, Sung-Hoon: 2 articles (05/2014 - 01/2011)|
|5.||Jo, Sung-Pil: 1 article (08/2014)|
|6.||Kim, Ji Sung: 1 article (05/2014)|
|7.||Kang, Chi Gu: 1 article (05/2014)|
|8.||Rasamison, Vincent E: 1 article (12/2013)|
|9.||Harinantenaina, Liva: 1 article (12/2013)|
|10.||Randrianaivo, Richard: 1 article (12/2013)|
01/01/2005 - "Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies."
01/01/2005 - "Rhapontigenin is an active anti-cancer compound. "
04/01/2001 - "These results suggest that rhapontigenin is a potent mechanism-based inactivator of human P450 1A1 and may be considered as a good candidate for a cancer chemopreventive agent in humans."
01/01/2005 - "Rhapontigenin demonstrated concentration-dependent anti-cancer activity with an IC50 115 microg/mL in HEP G2 cells while rhaponticin showed no activity across the concentrations tested in vitro. "
01/01/2011 - "Also, rhapontigenin suppressed hypoxia-induced HIF-1α activation in various cancer cells, such as colorectal adenocarcinoma (SW620), breast adenocarcinoma (MCF-7), fibrosarcoma (HT-1080) and prostate carcinoma (LNCaP). "
|3.||Prostatic Neoplasms (Prostate Cancer)
01/01/2011 - "In the present study, the inhibitory mechanism of rhapontigenin isolated from Vitis coignetiae was investigated on HIF-1α stability and angiogenesis in human prostate cancer PC-3 cells. "
01/01/2011 - "Taken together, these findings suggest that rhapontigenin inhibits HIF-1α accumulation and angiogenesis in PC-3 prostate cancer cells."
01/01/2011 - "Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells."
12/11/2006 - "In this study, human neuroblastoma cells (IMR-32) was used as system model to evaluate the protective role of rhaponticin (3,3',5-trihydroxy-4'-methoxystilbene 3-O-d-glucoside) a stilbene glucoside extracted from rhubarb roots (Rhei rhizoma) and rhapontigenin, its aglycone metabolite, against amyloid beta (1-42)-dependent toxicity. "
|5.||Breast Neoplasms (Breast Cancer)
05/23/2014 - "Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells."
08/01/2011 - "TMS (2,3',4,5'-tetramethoxystilbene), a stilbene analog derived from rhapontigenin, was previously demonstrated to induce apoptosis in hormone-resistant breast cancer cells. "
|3.||Amyloid (Amyloid Fibrils)
|4.||2',3',4',5'- tetrahydroxystilbene- 2- O- beta- D- glucoside
|6.||Hypoxia-Inducible Factor 1
|7.||Monophenol Monooxygenase (Tyrosinase)
|8.||Messenger RNA (mRNA)